dc.contributor.author | Oner-Iyidogan, YILDIZ | |
dc.date.accessioned | 2021-03-03T17:31:35Z | |
dc.date.available | 2021-03-03T17:31:35Z | |
dc.identifier.citation | Oner-Iyidogan Y., "Reply by authors to "Handling of commercially available enzyme immunoassays for 8-iso-prostaplandin F-2 alpha (8-iso-PGF(2 alpha),ipf(2 alpha)-III, 15-F-2t-IsoP) in clinical research and science: consideration from the analytical and review point of view"", CLINICA CHIMICA ACTA, cilt.344, ss.219-220, 2004 | |
dc.identifier.issn | 0009-8981 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_4a2f923d-928c-4efa-a9d8-f93466c0a54b | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/53302 | |
dc.identifier.uri | https://doi.org/10.1016/j.cccn.2004.01.025 | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | TIBBİ LABORATUVAR TEKNOLOJİSİ | |
dc.title | Reply by authors to "Handling of commercially available enzyme immunoassays for 8-iso-prostaplandin F-2 alpha (8-iso-PGF(2 alpha),ipf(2 alpha)-III, 15-F-2t-IsoP) in clinical research and science: consideration from the analytical and review point of view" | |
dc.type | Makale | |
dc.relation.journal | CLINICA CHIMICA ACTA | |
dc.contributor.department | İstanbul Üniversitesi , İstanbul Tıp Fakültesi , Temel Tıp Bilimleri Bölümü | |
dc.identifier.volume | 344 | |
dc.identifier.startpage | 219 | |
dc.identifier.endpage | 220 | |
dc.contributor.firstauthorID | 56337 | |